Literature DB >> 17515589

Drug-eluting stents.

Stéphane Rinfret, Erick Schampaert.   

Abstract

Mesh：

Year:  2007        PMID： 17515589      PMCID： PMC1867850          DOI： 10.1503/cmaj.1070021

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

Review 1.  The cost-effectiveness of drug-eluting stents: a systematic review.

Authors:  Suzanne Ligthart; Floortje Vlemmix; Nandini Dendukuri; James M Brophy
Journal:  CMAJ       Date:  2006-12-19       Impact factor: 8.262

2.  Cost effectiveness of the sirolimus-eluting stent in high-risk patients in Canada: an analysis from the C-SIRIUS trial.

Authors:  Stéphane Rinfret; David J Cohen; Amir A Tahami Monfared; Jacques Lelorier; Jean Mireault; Erick Schampaert
Journal:  Am J Cardiovasc Drugs       Date:  2006       Impact factor: 3.571

3.  Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.

Authors:  David J Cohen; Ameet Bakhai; Chunxue Shi; Louise Githiora; Tara Lavelle; Ronna H Berezin; Martin B Leon; Jeffrey W Moses; Joseph P Carrozza; James P Zidar; Richard E Kuntz
Journal:  Circulation       Date:  2004-07-19       Impact factor: 29.690

4.  The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS).

Authors:  Erick Schampaert; Eric A Cohen; Michael Schlüter; François Reeves; Mouhieddin Traboulsi; Lawrence M Title; Richard E Kuntz; Jeffrey J Popma
Journal:  J Am Coll Cardiol       Date:  2004-03-17       Impact factor: 24.094
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.